Fox Chase Cancer Center 333 Cottman Avenue — Philadelphia, Pennsylvania

Fox Chase Cancer Center 333 Cottman Avenue is a clinical research site located in Philadelphia, Pennsylvania, United States 19111.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center 333 Cottman Avenue has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Sponsors: Philogen S.p.A..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center 333 Cottman Avenue?

Fox Chase Cancer Center 333 Cottman Avenue has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center 333 Cottman Avenue conducted?

Fox Chase Cancer Center 333 Cottman Avenue has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Is Fox Chase Cancer Center 333 Cottman Avenue accredited by Crixeo Health?

Fox Chase Cancer Center 333 Cottman Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center 333 Cottman Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.